Clinical Trial Update: Sonlicromanol in Post-COVID [Phase 2]

View source ↗

Summary

This update indicates that Sonlicromanol is being studied in a Phase 2 trial for Post-acute sequelae of SARS-CoV-2 infection (Post-COVID Condition) and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Sonlicromanol

Snippet

Sponsor: Michele van Vugt | Conditions: Post COVID Condition | Phase 2 | Status: RECRUITING